MolNFT v1 · #114625 · protein
The structure of bacillus pumilus GH48 in complex with cellobiose
5BV9 · Cellulose 1,4-beta-cellobiosidase: “The structure of bacillus pumilus GH48 in complex with cellobiose”. X-ray diffraction, 2 ligands (BGC, CA), 2 pockets (best druggability 0.84). MolNFT v1 #114625 on GenesisL1: 3D structure…
- PDB
- 5BV9
- Type
- protein
- Length
- 701 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Cellulose 1,4-beta-cellobiosidase
- EC
- 3.2.1.91
- UniProt
- A8FDC4
- Ligands
- BGC, CA
- Pockets
- 2 · best druggability 0.84
Structure
x-ray diffraction · 1 distinct chain · 36% helix, 18% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Cellulose 1,4-beta-cellobiosidase (EC 3.2.1.91) | protein | 701 | 36% helix, 18% strand | A8FDC4 |
Ligands and binding sites
- BGC · beta-D-glucopyranose · sugar · 2 copies · chains A
- CA · Calcium ion · metal · 3 copies · chains A
- ACT · Acetate ion · additive · 6 copies · chains A
- EDO · 1,2-ethanediol · additive · 3 copies · chains A
- GOL · Glycerol · additive · 3 copies · chains A
- MLI · Malonate ion · additive · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1191 | 0.84 | 0.85 | 119 | BGC, MLI, EDO, ACT |
| 2 | 57 | 0.26 | 0.73 | 13 | empty |
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A8FDC4
- Elsewhere: RCSB PDB 5BV9 · PDBe 5BV9 · UniProt A8FDC4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.